Vibeke Strand, M.D.

Adjunct Clinical Professor, Division of Immunology and Rheumatology, Stanford University School of Medicine

Dr. Strand has served as an adjunct clinical professor in the Division of Immunology and Rheumatology at Stanford University School of Medicine since 1993, previously at UCSF. Since 1991, she has led a consulting practice offering clinical research and regulatory strategy expertise to pharmaceutical and biotech companies for development of new therapies in rheumatic diseases. She has participated in the development of all the approved biologic agents and targeted synthetic DMARDs in RA, as well as new therapies for PsA, SpA, SLE, vasculitis, gout, biosimilars and symptomatic therapies in OA. She was previously a clinical investigator in subspecialty practice in San Francisco for six years, and senior director of clinical research at three pharmaceutical/biotech companies for six years. She has authored more than 490 publications, is a Fellow of the American College of Physicians (1982), Master of the American College of Rheumatology (2015) and member of the Cosmos Club (1994). She has been a member of the Executive Committee of the international Outcomes in Rheumatology Clinical Trials (OMERACT) consensus conferences since its inception in 1992; Steering Committee of Group for Research and Assessment of PsO and PsA (GRAPPA); and Board of International Dermatology Outcome Measures (IDEOM).